Revision as of 00:42, 2 April 2021 editLegionMammal978 (talk | contribs)Extended confirmed users7,894 editsm corrected primes← Previous edit | Revision as of 21:25, 1 October 2024 edit undo76.174.0.57 (talk) Improvements.Next edit → | ||
Line 28: | Line 28: | ||
| Density = | | Density = | ||
| MeltingPtC = 184.5 | | MeltingPtC = 184.5 | ||
| MeltingPt_ref= <ref name="GanellinTriggle1996" /> | |||
| MeltingPt_ref= <ref name=Ganellin>{{cite book | title = Dictionary of Pharmacological Agents | volume = 3 | vauthors = Ganellin CR, Triggle DJ | publisher = CRC Press | date = 1996}}</ref> | |||
| BoilingPt = | | BoilingPt = | ||
| Solubility = }} | | Solubility = }} | ||
Line 48: | Line 48: | ||
}} | }} | ||
'''Imuracetam''' is a drug of the ] |
'''Imuracetam''' ({{Abbrlink|INN|International Nonproprietary Name}}; developmental code name '''UCB-G218''') is a ] of the ] group described as a ] (cognitive enhancer).<ref name="Elks2014">{{cite book | last=Elks | first=J. | title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies | publisher=Springer US | year=2014 | isbn=978-1-4757-2085-3 | url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA681 | access-date=1 October 2024 | page=681}}</ref><ref name="AvetisyanKocharovAzaryan1998">{{cite journal | vauthors = Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG | title = Synthesis and psychotropic activity of new 2-pyrrolidone derivatives. | journal = Pharmaceutical Chemistry Journal | date = February 1998 | volume = 32 | issue = 2 | pages = 55–58 | doi = 10.1007/BF02464161 | s2cid = 29810469 }}</ref> It was under development in the 1970s but was never marketed.<ref name="GanellinTriggle1996">{{cite book | title = Dictionary of Pharmacological Agents | volume = 3 | vauthors = Ganellin CR, Triggle DJ | publisher = CRC Press | date = 1996}}</ref> | ||
==References== | ==References== | ||
{{ |
{{Reflist}} | ||
{{Racetams}} | {{Racetams}} | ||
] | ] | ||
⚫ | ] | ||
] | ] | ||
] | |||
] | ] | ||
⚫ | ] | ||
{{ |
{{Nervous-system-drug-stub}} |
Revision as of 21:25, 1 October 2024
Names | |
---|---|
Preferred IUPAC name N,N′-Bisurea | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C11H18N4O3 |
Molar mass | 254.290 g·mol |
Melting point | 184.5 °C (364.1 °F; 457.6 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
Imuracetam (INNTooltip International Nonproprietary Name; developmental code name UCB-G218) is a drug of the racetam group described as a nootropic (cognitive enhancer). It was under development in the 1970s but was never marketed.
References
- ^ Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 3. CRC Press.
- Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 681. ISBN 978-1-4757-2085-3. Retrieved 1 October 2024.
- Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG (February 1998). "Synthesis and psychotropic activity of new 2-pyrrolidone derivatives". Pharmaceutical Chemistry Journal. 32 (2): 55–58. doi:10.1007/BF02464161. S2CID 29810469.
Racetams | |
---|---|
Racetams |
|
Phenylpiracetams |
|
Racetam-like |
|
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |